Download PDF
Horm Metab Res 2014; 46(05): 333-340
DOI: 10.1055/s-0034-1371858
Endocrine Research
© Georg Thieme Verlag KG Stuttgart · New York

Effect of Fructose and 3,5-Diiodothyronine (3,5-T2) on Lipid Accumulation and Insulin Signalling in Non-Alcoholic Fatty Liver Disease (NAFLD)-Like Rat Primary Hepatocytes

D. Gnocchi
1   Department of Biology and Biotechnology “Charles Darwin”, Sapienza University of Rome, Rome, Italy
,
M. Massimi
2   Department of Life, Health and Environmental Sciences, University of L’Aquila, L’Aquila, Italy
,
A. Alisi
3   Liver Research Unit and Hepato-Metabolic Disease Unit, “Bambino Gesù” Children’s Hospital, IRCCS, Rome, Italy
,
S. Incerpi
4   Department of Sciences, University Roma Tre, Rome, Italy
,
G. Bruscalupi
1   Department of Biology and Biotechnology “Charles Darwin”, Sapienza University of Rome, Rome, Italy
› Author Affiliations
Further Information

Publication History

received 05 August 2013

accepted after second revision 26 February 2014

Publication Date:
09 May 2014 (online)

Also available at
    Permissions and Reprints

Abstract

Non-alcoholic fatty liver disease (NAFLD) is nowadays considered as one of the most serious pathological conditions affecting the liver. NAFLD is supposed to be initiated by the accumulation of lipids in the liver, which finally results in an impaired hepatic insulin signalling. Many researchers have recently focused their attention on the role played by fructose as a NAFLD-triggering agent, because of the increased diffusion of fructose-sweetened food. However, epidemiological data do not permit to evaluate the role of fructose per se, because these foods are often associated with elevated energy intake and unhealthy lifestyle. In the present work, we analysed the effects of fructose on the accumulation of lipids and insulin signalling in rat primary hepatocytes. Moreover, we investigated the effect of the thyroid hormone metabolite, devoid of thyrotoxic effects, 3,5-diiodothyronine (3,5-T2) over the same parameters. To evaluate the effect on insulin signalling we took into consideration three key proteins, such as p85 subunit of phosphatidylinositol 3-kinase (PI3K), phosphatase and tensin homolog (PTEN), and Akt. Our results show that fructose in vitro, in the range of physiological concentrations, was not able to stimulate either lipid accumulation or to impair insulin signalling in our NAFLD-like rat primary hepatocytes. Our data thus support the idea that fructose per se may exert detrimental effects mainly triggering systemic effects, rather than directly affecting isolated hepatocytes. Moreover, we demonstrated that 3,5-T2, at physiological levels, reduces lipid content and triggers phosphorylation of Akt in an insulin receptor-independent manner, revealing new interesting properties as a biologically active molecule.

Key words

insulin signal transduction - Akt - p85 - PTEN

Supporting Information

    for this article is available online at http://www.thieme-connect.de/ejournals/toc/hmr
  • Supporting Information
 

  • References

  • 1 Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010; 28: 155-161
    CrossrefPubMedGoogle Scholar
  • 2 White JS. Straight talk about high-fructose corn syrup: what it is and what it ain’t. Am J Clin Nutr 2008; 88: 1716S-1721S
    CrossrefPubMedGoogle Scholar
  • 3 Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med 2011; 1364: 2392-2404
    PubMedGoogle Scholar
  • 4 Day CP, James OFW. Steatohepatitis: a tale of two “hits”?. Gastroenterology 1998; 114: 842-845
    CrossrefPubMedGoogle Scholar
  • 5 Samuel VT, Shulman GI. Mechanisms for Insulin Resistance: Common Threads and Missing Links. Cell 2012; 148: 852-871
    CrossrefPubMedGoogle Scholar
  • 6 Mauvais-Jarvis F, Ueki K, Fruman DA, Hirshman MF, Sakamoto K, Goodyear LJ, Iannacone M, Accili D, Cantley LC, Kahn CR. Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. J Clin Invest 2002; 109: 141-149
    CrossrefPubMedGoogle Scholar
  • 7 Shen YH, Zhang L, Gan Y, Wang X, Wang J, LeMaire SA, Coselli JS, Wang XL. Up-regulation of PTEN (phosphatase and tensin homolog deleted on chromosome ten) mediates p38 MAPK stress signal-induced inhibition of insulin signalling. A cross-talk between stress signaling and insulin signaling in resistin-treated human endothelial cells. J Biol Chem 2006; 281: 7727-7736
    CrossrefPubMedGoogle Scholar
  • 8 Liu HY, Collins QF, Xiong Y, Moukdar F, Lupo Jr EG, Liu Z, Cao W. Prolonged treatment of primary hepatocytes with oleate induces insulin resistance through p38 mitogen-activated protein kinase. J Biol Chem 2007; 282: 14205-14212
    CrossrefPubMedGoogle Scholar
  • 9 Lee SK, Lee JO, Kim JH, Kim SJ, You GY, Moon JW, Jung JH, Park SH, Uhm KO, Park JM, Suh PG, Kim HS. Metformin sensitizes insulin signaling through AMPK-mediated PTEN down-regulation in preadipocyte 3T3-L1 cells. J Cell Biochem 2011; 112: 1259-1267
    CrossrefPubMedGoogle Scholar
  • 10 Arnold S, Goglia F, Kadenbach B. 3,5-diiodothyronine binds to subunit Va of cytochrome c oxidase and abolishes the allosteric inhibition of respiration by ATP. Eur J Biochem 1998; 252: 325-330
    CrossrefPubMedGoogle Scholar
  • 11 Lombardi A, Beneduce L, Moreno M, Diano S, Colantuoni V, Ursini MV, Lanni A, Goglia F. 3,5-Diiodo-l-Thyronine Regulates Glucose-6-Phosphate Dehydrogenase Activity in the Rat. Endocrinology 2000; 141: 1729-1734
    CrossrefPubMedGoogle Scholar
  • 12 Cavallo A, Priore P, Gnoni GV, Papa S, Zanotti F, Gnoni A. 3,5-Diiodo-l-thyronine administration to hypothyroid rats rapidly enhances fatty acid oxidation rate and bioenergetic parameters in liver cells. PLoS ONE 2013; 8: e52328
    CrossrefPubMedGoogle Scholar
  • 13 Mollica MP, Lionetti L, Moreno M, Lombardi A, De Lange P, Antonelli A, Lanni A, Cavaliere G, Barletta A, Goglia F. 3,5-diiodo-l-thyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet. J Hepatol 2009; 51: 363-370
    CrossrefPubMedGoogle Scholar
  • 14 Yen PM. Physiological and Molecular Basis of Thyroid Hormone Action. Physiol Rev 2001; 81: 1097-1142
    CrossrefPubMedGoogle Scholar
  • 15 Ball SG, Sokolov J, Chin WW. 3,5-Diiodo-l-thyronine (T2) has selective thyromimetic effects in vivo and in vitro. J Mol Endocrinol 1997; 19: 137-1472
    CrossrefPubMedGoogle Scholar
  • 16 Vidyashankar S, Sandeep Varma R, Patki PS. Quercetin ameliorates insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells. Toxicol In Vitro 2013; 27: 945-953
    CrossrefPubMedGoogle Scholar
  • 17 Moldeus P, Högberg J, Orrenius S. Isolation and use of liver cells. Methods Enzymol 1978; 52: 60-71
    PubMedGoogle Scholar
  • 18 De Colli M, Massimi M, Barbetta A, Di Rosario BL, Nardecchia S, Conti Devirgiliis L, Dentini M. A biomimetic porous hydrogel of gelatin and glycosaminoglycans cross-linked with transglutaminase and its application in the culture of hepatocytes. Biomed Mater 2012; 7: 055005
    CrossrefPubMedGoogle Scholar
  • 19 Koopman R, Schaart G, Hesselink MK. Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids. Histochem Cell Biol 2001; 116: 63-68
    PubMedGoogle Scholar
  • 20 Repetto G, del Peso A, Zurita JL. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc 2008; 3: 1125-1131
    CrossrefPubMedGoogle Scholar
  • 21 Ohkawa H, Ohishi N, Yagi K. Assay for Lipid Peroxides in Animal Tissues by Thiobarbituric Acid Reaction. Anal Biochem 1979; 95: 351-358
    CrossrefPubMedGoogle Scholar
  • 22 Bucio L, Souza V, Albores A, Sierra A, Chávez E, Cárabez A, Gutierrérrez-Ruiz MC. Cadmium and mercury toxicity in a human fetal hepatic cell line (WRL-68 cells). Toxicology 1995; 102: 285-299
    CrossrefPubMedGoogle Scholar
  • 23 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275
    PubMedGoogle Scholar
  • 24 Peterson GL. Review of the Folin Phenol Protein Quantitation Method of Lowry, Rosebrough, Farr, and Randall. Anal Biochem 1979; 100: 201-220
    CrossrefPubMedGoogle Scholar
  • 25 Segal MS, Gollub E, Johnson RJ. Is the fructose index more relevant with regards to cardiovascular disease than the glycemic index?. Eur J Nutr 2007; 46: 406-417
    CrossrefPubMedGoogle Scholar
  • 26 Wiersinga WM, Chopra IJ. Radioimmunoassay of thyroxine (T4), 3,5,3′-triiodothyronine (T3), 3,3′,5′-triiodothyronine (reverse T3, rT3), and 3,3′-diiodothyronine (T2). Methods Enzymol 1982; 84: 272-303
    PubMedGoogle Scholar
  • 27 Pinna G, Meinhold H, Hiedra L, Thoma R, Hoell T, Gräf KJ, Stoltenburg-Didinger G, Eravci M, Prengel H, Brödel O, Finke R, Baumgartner A. Elevated 3,5-Diiodothyronine Concentrations in the Sera of Patients with Nonthyroidal Illnesses and Brain Tumors. J Clin Endocrinol Metab 1997; 82: 1535-1542
    CrossrefPubMedGoogle Scholar
  • 28 Moreno M, Lombardi A, Beneduce L, Silvestri E, Pinna G, Goglia F, Lanni A. Are the effects of T3 on Resting Metabolic Rate in Euthyroid Rats Entirely Caused by T3 itself?. Endocrinology 2002; 143: 504-510
    CrossrefPubMedGoogle Scholar
  • 29 Sievenpiper JL, de Souza RJ, Mirrahimi A, Yu ME, Carleton AJ, Beyene J, Chiavaroli L, Di Buono M, Jenkins AL, Leiter LA, Wolever TM, Kendall CW, Jenkins D. Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis. Ann Intern Med 2012; 156: 291-304
    CrossrefPubMedGoogle Scholar
  • 30 Lê KA, Ith M, Kreis R, Faeh D, Bortolotti M, Tran C, Boesch C, Tappy L. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr 2009; 89: 1760-1765
    CrossrefPubMedGoogle Scholar
  • 31 Huang D, Dhawan T, Young S, Yong WH, Boros LG, Heaney AP. Fructose impairs glucose-induced hepatic triglyceride synthesis. Lipids Health Dis 2011; 10: 20
    CrossrefPubMedGoogle Scholar
  • 32 Li P, Koike T, Qin B, Kubota M, Kawata Y, Jia YJ, Oshida Y. A High-fructose Diet Impairs Akt and PKCζ Phosphorylation and GLUT4 Translocation in Rat Skeletal Muscle. Horm Metab Res 2008; 40: 528-532
    Article in Thieme ConnectPubMedGoogle Scholar
  • 33 Kanuri G, Spruss A, Wagnerberger S, Bischoff SC, Bergheim I. Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice. J Nutr Biochem 2011; 22: 527-534
    CrossrefPubMedGoogle Scholar
  • 34 Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, Bergheim I. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 2009; 50: 1094-1104
    CrossrefPubMedGoogle Scholar
  • 35 Alisi A, Pastore A, Ceccarelli S, Panera N, Gnani D, Bruscalupi G, Massimi M, Tozzi G, Piemonte F, Nobili V. Emodin prevents intrahepatic fat accumulation, inflammation and redox status imbalance during diet-induced hepatosteatosis in rats. Int J Mol Sci 2012; 13: 2276-2289
    CrossrefPubMedGoogle Scholar
  • 36 Kohli R, Kirby M, Xanthakos SA, Softic S, Feldstein AE, Saxena V, Tang PH, Miles L, Miles MV, Balistreri WF, Woods SC, Seeley RJ. High-fructose medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology 2010; 52: 934-944
    CrossrefPubMedGoogle Scholar
  • 37 Ueki K, Fruman DA, Brachmann SM, Tseng YH, Cantley LC, Kahn CR. Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival. Mol Cell Biol 2002; 22: 965-977
    CrossrefPubMedGoogle Scholar
  • 38 Grasselli E, Voci A, Canesi L, De Matteis R, Goglia F, Cioffi F, Fugassa E, Gallo G, Vergani L. Direct effects of iodothyronines on excess fat storage in rat hepatocytes. J Hepatol 2011; 54: 1230-1236
    CrossrefPubMedGoogle Scholar
  • 39 Incerpi S, De Vito P, Luly P, Spagnuolo S, Leoni S. Short term effects of thyroid hormones and 3,5-diiodothyronine on membrane transport systems in chick embryo hepatocytes. Endocrinology 2002; 143: 1660-1668
    CrossrefPubMedGoogle Scholar
  • 40 Rochira A, Damiano F, Marsigliante S, Gnoni GV, Siculella L. 3,5-Diiodo-L-thyronine induces SREBP-1 proteolytic cleavage block and apoptosis in human hepatoma (Hepg2) cells. Biochim Biophys Acta 2013; 1831: 1679-1689
    CrossrefPubMedGoogle Scholar
  • 41 de Lange P, Cioffi F, Senese R, Moreno M, Lombardi A, Silvestri E, De Matteis R, Lionetti L, Mollica MP, Goglia F, Lanni A. Nonthyrotoxic Prevention of Diet-Induced Insulin Resistance by 3,5-Diiodo-l-Thyronine in Rats. Diabetes 2011; 60: 2730-2739
    CrossrefPubMedGoogle Scholar
  • 42 Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr Rev 2010; 31: 139-170
    CrossrefPubMedGoogle Scholar
  • 43 Scapin S, Leoni S, Spagnuolo S, Gnocchi D, De Vito P, Luly P, Pedersen JZ, Incerpi S. Short-term effects of thyroid hormones during development: Focus on signal transduction. Steroids 2010; 75: 576-584
    CrossrefPubMedGoogle Scholar
  • 44 Gnocchi D, Leoni S, Incerpi S, Bruscalupi G. 3,5,3′-triiodothyronine (T3) stimulates cell proliferation through the activation of the PI3K/Akt pathway and reactive oxygen species (ROS) production in chick embryo hepatocytes. Steroids 2012; 77: 589-595
    CrossrefPubMedGoogle Scholar
  • 45 Moeller LC, Cao X, Dumitrescu AM, Seo H, Refetoff S. Thyroid hormone mediated changes in gene expression can be initiated by cytosolic action of the thyroid hormone receptor beta through the phosphatidylinositol 3-kinase pathway. Nucl Recept Signal 2006; 4: e020
    CrossrefPubMedGoogle Scholar
  • 46 Grasselli E, Voci A, Canesi L, Goglia F, Ravera S, Panfoli I, Gallo G, Vergani L. Non-receptor-mediated actions are responsible for the lipid-lowering effects of iodothyronines in FaO rat hepatoma cells. J Endocrinol 2011; 210: 59-69
    CrossrefPubMedGoogle Scholar
  • 47 Moreno M, Silvestri E, Lombardi A, Visser TJ, Goglia F, Lanni A. Identification of 3,5-Diiodo-l-Thyronine-Binding Proteins in Rat Liver Cytosol by Photoaffinity Labeling. Endocrinology 2003; 144: 2297-2203
    CrossrefPubMedGoogle Scholar
  • 48 Vatner DF, Weismann D, Beddow SA, Kumashiro N, Erion DM, Liao XH, Grover GJ, Webb P, Phillips KJ, Weiss RE, Bogan JS, Baxter J, Shulman GI, Samuel VT. Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways. Am J Physiol Endocrinol Metab 2013; 305: E89-E100
    CrossrefPubMedGoogle Scholar
  • 49 Mousa SA, O’Connor LJ, Bergh JJ, Davis FB, Scanlan TS, Davis PJ. The proangiogenic action of thyroid hormone analogue GC-1 is initiated at an integrin. J Cardiovasc Pharmacol 2005; 46: 356-360
    CrossrefPubMedGoogle Scholar